Skip to content
Government Federal, Medical Health Aged Care

New telehealth rules set to undermine access to advanced nurses

Australian College of Nursing 2 mins read

New telehealth rules starting today will restrict nurse practitioners’ (NP) ability to deliver high-quality healthcare – a loss to Australians, particularly in remote and regional areas.

 

Patients of independent nurse practitioners will now be required to have had at least one face-to-face appointment within the prior 12 months to be able to claim a Medicare rebate for a telehealth appointment.

 

“In a health system desperately short of clinicians, independent nurse practitioners are a hugely valuable asset that we should be encouraging and supporting,” said Australian College of Nursing Chief Nursing Officer, Frances Rice.

 

“We need to be using each and every health professional’s skills and expertise to their full extent.

 

“Yet at every turn, nurse practitioners have to fight tooth and nail to be able to deliver care within a system that is often hostile to them.

 

“The telehealth rules are just the latest example of this.”

 

While general practitioners are exempt from the new ‘one-in-twelve’ rule if they are registered with the MyMedicare system, independent nurse practitioners are excluded from registering with MyMedicare.

 

“Nurse practitioners must be allowed to register with MyMedicare to enable them to deliver the high-quality, advanced care they are trained for and expert in,” said Ms Rice.

 

Nurse practitioners are the only regulated advanced nursing practice role in Australia. They work autonomously as generalist or specialist practitioners, with the authority to diagnose, prescribe medications and treat complex conditions.

“Nurse practitioners have been a regulated role in Australia since 2000 – yet they are hindered by a lack of support from the system,” says Ms Rice.

While the nurse practitioner workforce in Australia has expanded significantly between 2019 and 2024, with registrations increasing by 52.8% (from 1,876 to 2,867), this expansion is not matched by proportional utilisation:

  • Non-employment among NPs doubled from 51 to 103 — a 102% increase,
  • NPs not in the labour force rose by 72.4%, from 58 to 100,
  • Between 2020 and 2024, those employed specifically as NPs grew by 31.9%, but those not employed as NPs surged by 71.6%.

These figures reveal a widening gap between workforce capacity and actual deployment, pointing to systemic barriers that limit the full integration of NPs into the health system

To close the utilisation gap and fully realise the value of the NP workforce, Australia must:

  • Expand NP roles across primary care, aged care, and rural health,
  • Reform funding and regulatory frameworks to support full scope of practice,
  • Align workforce planning with service delivery needs,
  • Invest in retention and career development, ensuring NPs are supported, valued, and empowered to lead care.

“While ever we hobble the nurse practitioner workforce from using all of their skills and expertise, Australians are missing out,” said Ms Rice.

“The health system can’t afford this inefficiency and we must do better.”


Contact details:

Lexi Metherell 0449 803 524

[email protected]

Media

More from this category

  • General News, Government Federal
  • 12/11/2025
  • 07:00
e61 Institute

New research reveals GST inequity

Australia's complex web of GST exemptions is causing households which spend similar amounts each year to pay significantly different rates of tax, new research by the e61-UNSW Policy Research Partnership has shown. The study of the latest Household Expenditure Survey shows that among households spending about $38,000 a year, GST paid ranges from roughly $2,100 to $3,400 — meaning some pay around 37% more GST than others, despite spending the same overall amount. The variation is caused by Australia exempting so many items from theGST, such as certain types of food, health care and education fees. This means the amount…

  • Medical Health Aged Care
  • 12/11/2025
  • 07:00
RMIT University

Blood test offers hope for more effective ovarian cancer treatment

New clinical research has identified a blood test that can reveal which women are more likely to respond to particular treatment for ovarian cancer,…

  • Contains:
  • Medical Health Aged Care
  • 11/11/2025
  • 16:00
Uniting NSW.ACT

Results of Australia’s first injectable opioid treatment trial announced at 2025 APSAD conference

Media Release 11th November 2025 The results of Australia’s first injectable opioid treatment trial were revealed at the 2025 APSAD (The Australasian Professional Society on Alcohol and other Drugs) conference in Sydney today. Two presentations today outlined the initial findings of the trial – one by Dr Jake Rance, Centre for Social Research in Health at UNSW on ‘The ‘acceptability’ of supervised injectable opioid treatment: Staff and participant reflections from the Australian ‘Feasibility of Injectable Opioid Treatment’ (FOpIT) and the other by Dr Craig Rodgers on the initial outcomes of recruitment, retention and safety. The study is a partnership between…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.